Inventia
Resource Hub

Use our resource hub to learn more about RASTRUM™ for your 3D cell culture needs and explore peer-reviewed publications powered by RASTRUM.

Our in-house curated application notes highlight the applicability and capability of the RASTRUM Platform. 

Discover how the platform can be utilized for a particular application to support impactful scientific research.
World first: 3D bioprinter installed at Peter Mac to accelerate cancer research View No Type RASTRUM™ Platform workflow View No Type PhenoVue™ In Situ Live/Dead Cell Viability with RASTRUM™ 3D Advanced Cell Models View No Type Incorporation of DQ™ collagen type I bovine skin, fluorescein conjugate into RASTRUM™ Matrix View No Type Three‐dimensional bioprinting of stem cell‐derived central nervous system cells enables astrocyte growth, vasculogenesis, and enhances neural differentiation/function View No Type Model parameter identification using 2D vs 3D experimental data: A comparative analysis View No Type Development of complex tissue architectures in 3D- Application note View No Type Studying fibroblast activation and production of extracellular matrix proteins with RASTRUM™ 3D cell models View No Type Liver 3D model using primary human hepatocytes View No Type Inventia Life Science Announces Third Dimension Grant for 3D Cell Culture Research View No Type Inventia continues global expansion into the Indian market through a distribution agreement for RASTRUM™ with Biotron Healthcare PVT Ltd View No Type Inventia Life Science collaborates with MSD to develop 3D advanced cell models for neurodegenerative disease drug discovery View No Type Inventia enters into a distribution agreement for RASTRUM™ with SCRUM Inc in Japan View No Type Inventia Life Science secures NSW Government Jobs Plus support to build a brand-new manufacturing and R&D facility in Sydney View No Type Inventia Life Science cements its US presence by opening its first US office and facility at The Innovation Space™ in Wilmington, Delaware View No Type Inventia has been named on the 2022 AFR BOSS Most Innovative Companies List View No Type Healthcare super fund HESTA directly invests in Inventia Life Science View No Type Clamping down on the causes of pre-eclampsia View No Type Inventia Life Science Accelerates Growth with AU$35 million Series B View No Type Australian company accelerating the speed of drug discovery wins prestigious Eureka prize View No Type